Therefore, potential diagnostic biomarkers have been proposed to improve diagnosis by differentiating AD and psoriasis in patients with psoriasiform dermatitis, namely nitric oxide synthase 2 (NOS2) and CTACK/CCL27 [82,83,84]. This evidence concerns the gene NOS2 and Alzheimer disease.